Synced daily from ClinicalTrials.gov via AACT. Last sync: .
6 Mazdutide clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 6 indications (including Type 2 Diabetes & Dementia, Mild) and 2,358 total planned enrollment. 2 Phase 3 Mazdutide trials and 1 Phase 2 are listed. 5 Mazdutide clinical trials are actively recruiting. Most recent activity: NCT07135141 (Sep 2029).
Mazdutide clinical trials at a glance: phase × recruitment status
Phase
recruiting
active not recruiting
not yet recruiting
Total
P1/P2
1
1
P2
1
1
P3
1
1
2
N/A
1
1
2
Recruiting Mazdutide clinical trials (5)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
SGLT2A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
6 Mazdutide clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are actively recruiting participants.
Are Mazdutide clinical trials recruiting in 2026?
Yes — 3 Mazdutide trials are actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
What conditions is Mazdutide being studied for?
Mazdutide is being studied for Type 2 Diabetes, Dementia, Mild, Mild Cognitive Impairment, Obesity, Polycystic Ovary Syndrome and 3 more. The trials are grouped by indication on this page.
What phase is Mazdutide in?
Mazdutide clinical trials span 2 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Mazdutide clinical trials?
The lead sponsor across the most Mazdutide trials is Shanghai Zhongshan Hospital, with 4 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Mazdutideas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.